11573/1692815 - 2023 -
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer Fiascarelli, Alessio; Merlino, Giuseppe; Capano, Stefania; Talucci, Simone; Bisignano, Diego; Bressan, Alessandro; Bellarosa, Daniela; Carrisi, Corrado; Paoli, Alessandro; Bigioni, Mario; Tunici, Patrizia; Irrissuto, Clelia; Salerno, Massimiliano; Arribas, Joaquin; De Stanchina, Elisa; Scaltriti, Maurizio; Binaschi, Monica - 01a Articolo in rivista
paper: BREAST CANCER RESEARCH AND TREATMENT (Dordrecht: Kluwer) pp. 13-23 - issn: 1573-7217 - wos: WOS:000948779600001 (6) - scopus: 2-s2.0-85149927212 (6)
11573/1341220 - 2019 -
MEN1309/OBT076, a first-in-class antibody–drug conjugate targeting CD205 in solid tumors Merlino, G.; Fiascarelli, A.; Bigioni, M.; Bressan, A.; Carrisi, C.; Bellarosa, D.; Salerno, M.; Bugianesi, R.; Manno, R.; Morales, C. B.; Arribas, J.; Dusek, R. L.; Ackroyd, J. E.; Pham, P. H.; Awdew, R.; Aud, D.; Trang, M.; Lynch, C. M.; Terrett, J.; Wilson, K. E.; Rohlff, C.; Manzini, S.; Pellacani, A.; Binaschi, M. - 01a Articolo in rivista
paper: MOLECULAR CANCER THERAPEUTICS (Philadelphia, PA : American Association for Cancer Research, c2001-) pp. 1533-1543 - issn: 1535-7163 - wos: WOS:000484118200006 (15) - scopus: 2-s2.0-85071782365 (17)